• Skip to primary navigation
  • Skip to main content
Althea

Althea

Australian owned licensed importer and producer of medicinal cannabis

  • Medicinal Cannabis – The Basics
  • FAQ
  • Contact Us

Social

Twitter Update – 2020-02-27 05:31:24

Chris Smith · February 27, 2020 ·

The growth continues! Althea has officially reached over 5,000 patients. This is an exciting milestone and a great reflection of the relentless hard work from all of the team. Thank you to all our fantastic partners and we look forward to further continued growth in 2020. https://t.co/itYfbPQHZn

Facebook Update – 2019-07-15 03:13:13

Chris Smith · July 15, 2019 ·

Our CEO Josh Fegan sat down with @CommSec’s Tom Piotrowski to discuss our focus on education & technology to improve patient access to medicinal cannabis & the positive regulatory outlook for new jurisdictions & emerging markets | Video: http://ow.ly/BTEj50v0x8C

Facebook Update – 2019-06-24 23:53:24

Chris Smith · June 25, 2019 ·

Althea is thrilled to announce that we will supply the first UK national medical cannabis pilot targeting 20,000 patients | Read the ASX announcement here: https://www.asx.com.au/asxpdf/20190625/pdf/4462xcgx974f62.pdf $AGH

Facebook Update – 2019-06-05 01:26:40

Chris Smith · June 5, 2019 ·

The Motley Fool says “Althea Group could charge higher today”  | Read why here: https://www.fool.com.au/2019/06/05/why-cannabis-company-althea-group-could-charge-higher-today/ $AGH

Facebook Update – 2019-06-05 00:54:21

Chris Smith · June 5, 2019 ·

Althea Group Holdings is pleased to announce that we have been granted a Hemp Cultivation Licence and have entered into an exclusive agreement with Tissue Culture Australia | View our latest ASX announcement to learn more: http://ow.ly/zuvD50uwN4S

  • Page 1
  • Page 2
  • Go to Next Page »

We use cookies to provide and improve our services. By using our site, you consent to cookies. Learn More.

©2024 Althea Company Pty Ltd

Footer Logo

  • Home
  • FAQ
  • Adverse Event
  • Cookie Policy
  • Privacy Policy
  • Terms of Service
  • Investors